Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CEZAR ILIESCU and SAAMIR A HASSAN.
CEZAR ILIESCU
Connection Strength
4.642
SAAMIR A HASSAN
  1. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the "forgotten pulmonic valve". Front Cardiovasc Med. 2022; 9:1071138.
    View in: PubMed
    Score: 0.220
  2. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med. 2022; 9:1072890.
    View in: PubMed
    Score: 0.219
  3. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284.
    View in: PubMed
    Score: 0.215
  4. The Year in Cardio-oncology 2022. Curr Probl Cardiol. 2023 Jan; 48(1):101435.
    View in: PubMed
    Score: 0.214
  5. Post-cardiac arrest PCI is underutilized among cancer patients: Machine learning augmented nationally representative case-control study of 30 million hospitalizations. Resuscitation. 2022 10; 179:43-49.
    View in: PubMed
    Score: 0.212
  6. Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type: Machine Learning Supported Nationally Representative Case-Control Study of 30 Million Hospitalizations. Medicina (Kaunas). 2022 Jun 28; 58(7).
    View in: PubMed
    Score: 0.211
  7. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022; 9:916325.
    View in: PubMed
    Score: 0.209
  8. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience. JACC CardioOncol. 2021 Sep; 3(3):452-456.
    View in: PubMed
    Score: 0.198
  9. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis. 2021 Jun 01; 32(4):295-301.
    View in: PubMed
    Score: 0.195
  10. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med. 2020; 7:9.
    View in: PubMed
    Score: 0.179
  11. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep. 2019 11 19; 21(11):140.
    View in: PubMed
    Score: 0.176
  12. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
    View in: PubMed
    Score: 0.172
  13. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis? Curr Cardiol Rep. 2019 07 08; 21(8):83.
    View in: PubMed
    Score: 0.171
  14. Multimodality imaging in carcinoid heart disease. Open Heart. 2019; 6(1):e001060.
    View in: PubMed
    Score: 0.170
  15. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
    View in: PubMed
    Score: 0.166
  16. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019 02; 36(2):229-236.
    View in: PubMed
    Score: 0.165
  17. The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncol Lett. 2019 May; 17(5):4126-4132.
    View in: PubMed
    Score: 0.164
  18. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med. 2018; 5:48.
    View in: PubMed
    Score: 0.158
  19. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018 02 08; 20(2):10.
    View in: PubMed
    Score: 0.155
  20. Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol. 2017 Dec 15; 120(12):2284-2288.
    View in: PubMed
    Score: 0.151
  21. Carcinoid heart disease. Heart. 2017 10; 103(19):1488-1495.
    View in: PubMed
    Score: 0.148
  22. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep. 2017 Jun; 19(6):39.
    View in: PubMed
    Score: 0.148
  23. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
    View in: PubMed
    Score: 0.052
  24. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med. 2021; 8:734820.
    View in: PubMed
    Score: 0.050
  25. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type. ESC Heart Fail. 2021 12; 8(6):4626-4634.
    View in: PubMed
    Score: 0.050
  26. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep. 2021 09 27; 23(11):133.
    View in: PubMed
    Score: 0.050
  27. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med. 2021; 8:626414.
    View in: PubMed
    Score: 0.049
  28. Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med. 2021; 8:644264.
    View in: PubMed
    Score: 0.048
  29. QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021; 8:613625.
    View in: PubMed
    Score: 0.048
  30. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol. 2020 Apr; 99(4):781-789.
    View in: PubMed
    Score: 0.045
  31. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. Methodist Debakey Cardiovasc J. 2019 Oct-Dec; 15(4):258-266.
    View in: PubMed
    Score: 0.044
  32. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy. Curr Opin Cardiol. 2019 07; 34(4):441-450.
    View in: PubMed
    Score: 0.043
  33. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart. 2018; 5(2):e000881.
    View in: PubMed
    Score: 0.041
  34. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med. 2018 Mar 20; 20(4):29.
    View in: PubMed
    Score: 0.039
  35. The role of cardiac MRI in cardio-oncology. Future Cardiol. 2017 07; 13(4):311-316.
    View in: PubMed
    Score: 0.037
  36. Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):265-77.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.